Suppr超能文献

荷兰社区药房处方修改的性质、频率及决定因素。

Nature, frequency and determinants of prescription modifications in Dutch community pharmacies.

作者信息

Buurma H, de Smet P A, van den Hoff O P, Egberts A C

机构信息

SIR Institute for Pharmacy Practice Research, Leiden, The Netherlands.

出版信息

Br J Clin Pharmacol. 2001 Jul;52(1):85-91. doi: 10.1046/j.0306-5251.2001.01406.x.

Abstract

AIMS

To examine the nature, frequency and determinants of prescription modifications in Dutch community pharmacies.

METHODS

A prospective case-control study comparing modified prescriptions with nonmodified prescriptions was carried out in 141 Dutch community pharmacies. 2014 modified prescriptions (cases), collected in the selected pharmacies on a predetermined day in a specific period (25th February until 12th March 1999) and 2581 nonmodified prescriptions (controls) randomly selected on the same day were studied. The nature and frequency of prescription modifications and patient, drug and prescriber related determinants for a modified prescription were assessed.

RESULTS

The overall incidence of prescription modifications was 4.3%, with a mean of 14.3 modifications per pharmacy per day. For prescription only medicines (POM) the incidence was 4.9%. The majority of POM modifications concerned a clarification (71.8%). In 22.2% a prescription could potentially have had clinical consequences when not altered; in more than half of the latter it concerned a dose error (13.7% of all cases). POM prescriptions of patients of 40-65 years had a significantly lower chance of modification compared with those of younger people (OR = 0.74 [0.64-0.86]). With respect to medication-class, we found a higher chance of POM modifications in the respiratory domain (OR = 1.48 [1.23-1.79]) and a decreased chance for nervous system POMs (OR = 0.71 [0.61-0.83]). With regard to prescriber-related determinants modifications were found three times more often in non printed prescriptions than in printed ones (OR = 3.30 [2.90-3.75]). Compared with prescriptions by the patient's own GP, prescriptions of specialists (OR = 1.82 [1.57-2.11]), other GP's (OR = 1.49 [1.02-2.17]) and other prescribers such as dentists and midwives (OR = 1.95 [1.06-3.57]) gave a higher probability of prescription modifications. When a GP had no on-line access to the computer of the pharmacy the chance of a modification was also higher (OR = 1.61 [1.33-1.94]). Multivariate analysis revealed that a nonprinted prescription was the strongest independent determinant of prescription modifications (OR = 3.32 [2.87-3.84]), remaining so after adjustment for GP computer link to the pharmacy and for type of prescriber.

CONCLUSIONS

At least 30% of Dutch community pharmacies corrected 2.8 POM prescriptions per pharmacy per working day, which could potentially have had clinical consequences if not altered. If the study sample is representative for The Netherlands, Dutch community pharmacies correct a total of approximately 4400 of these prescriptions per working day. Using computerized systems to generate prescriptions is an important strategy to reduce the incidence of prescription errors.

摘要

目的

研究荷兰社区药房处方修改的性质、频率及决定因素。

方法

在141家荷兰社区药房开展一项前瞻性病例对照研究,将修改后的处方与未修改的处方进行比较。研究了2014份修改后的处方(病例),这些处方于特定时期(1999年2月25日至3月12日)的预定日期在选定药房收集,以及同日随机抽取的2581份未修改处方(对照)。评估了处方修改的性质和频率以及与修改处方相关的患者、药物和开处方者的决定因素。

结果

处方修改的总体发生率为4.3%,每家药房每天平均修改14.3次。仅用于处方药(POM)的处方发生率为4.9%。大多数POM修改涉及澄清(71.8%)。在22.2%的情况下,如果不改变处方可能会产生临床后果;其中超过一半涉及剂量错误(占所有病例的13.7%)。40 - 65岁患者的POM处方修改的可能性明显低于年轻人(OR = 0.74 [0.64 - 0.86])。在药物类别方面,我们发现呼吸领域的POM修改可能性更高(OR = 1.48 [1.23 - 1.79]),而神经系统POM的修改可能性降低(OR = 0.71 [0.61 - 0.83])。关于与开处方者相关的决定因素,在非打印处方中发现修改的频率是打印处方的三倍(OR = 3.30 [2.90 - 3.75])。与患者自己的全科医生开具的处方相比,专科医生开具的处方(OR = 1.82 [1.57 - 2.11])、其他全科医生开具的处方(OR = 1.49 [1.02 - 2.17])以及牙医和助产士等其他开处方者开具的处方(OR = 1.95 [1.06 - 3.57])修改的可能性更高。当全科医生无法在线访问药房的计算机时,修改的可能性也更高(OR = 1.61 [1.33 - 1.94])。多变量分析显示,非打印处方是处方修改的最强独立决定因素(OR = 3.32 [2.87 - 3.84]),在调整了全科医生与药房的计算机链接以及开处方者类型后仍然如此。

结论

至少30%的荷兰社区药房每个工作日每家药房纠正2.8份POM处方,如果不改变这些处方可能会产生临床后果。如果该研究样本代表荷兰,那么荷兰社区药房每个工作日总共纠正约4400份此类处方。使用计算机系统生成处方是减少处方错误发生率的重要策略。

相似文献

1
Nature, frequency and determinants of prescription modifications in Dutch community pharmacies.
Br J Clin Pharmacol. 2001 Jul;52(1):85-91. doi: 10.1046/j.0306-5251.2001.01406.x.
2
Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
Pharm World Sci. 2003 Dec;25(6):280-7. doi: 10.1023/b:phar.0000006521.41736.db.
3
Nature and frequency of prescription modifications in community pharmacies: A nationwide study in the Netherlands.
Br J Clin Pharmacol. 2021 Mar;87(3):1455-1465. doi: 10.1111/bcp.14548. Epub 2020 Sep 24.
4
Evaluation of the clinical value of pharmacists' modifications of prescription errors.
Br J Clin Pharmacol. 2004 Nov;58(5):503-11. doi: 10.1111/j.1365-2125.2004.02181.x.
5
Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions.
Drug Saf. 2006;29(8):723-32. doi: 10.2165/00002018-200629080-00009.
6
Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies.
Pharmacoepidemiol Drug Saf. 2005 May;14(5):327-32. doi: 10.1002/pds.1012.
7
Determinants of pharmacists' interventions linked to prescription processing.
Pharm World Sci. 2001 Jun;23(3):98-101. doi: 10.1023/a:1011261930989.
8
Preventing drug interactions by online prescription screening in community pharmacies and medical practices.
Clin Pharmacol Ther. 2001 Apr;69(4):260-5. doi: 10.1067/mcp.2001.114228.
9
Nature and frequency of drug therapy alerts generated by clinical decision support in community pharmacy.
Pharmacoepidemiol Drug Saf. 2016 Jan;25(1):82-9. doi: 10.1002/pds.3915. Epub 2015 Nov 25.
10
Analysis of community chain pharmacists' interventions on electronic prescriptions.
J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):59-64. doi: 10.1331/JAPhA.2009.08013.

引用本文的文献

1
Identification, classification, and documentation of drug related problems in community pharmacy practice in Europe: a scoping review.
Int J Clin Pharm. 2025 Apr;47(2):247-269. doi: 10.1007/s11096-024-01834-7. Epub 2025 Jan 8.
2
Pharmacists' interventions on prescribing errors in Malaysia.
J Pharm Policy Pract. 2024 Sep 23;17(1):2404974. doi: 10.1080/20523211.2024.2404974. eCollection 2024.
4
Pharmaceutical interventions on prescriptions in Norwegian community and hospital pharmacies.
Int J Clin Pharm. 2021 Aug;43(4):872-877. doi: 10.1007/s11096-020-01188-w. Epub 2020 Nov 6.
5
Nature and frequency of prescription modifications in community pharmacies: A nationwide study in the Netherlands.
Br J Clin Pharmacol. 2021 Mar;87(3):1455-1465. doi: 10.1111/bcp.14548. Epub 2020 Sep 24.
7
The Hidden Role of Community Pharmacy Technicians in Ensuring Patient Safety with the Use of E-Prescribing.
Pharmacy (Basel). 2015 Dec;3(4):330-343. doi: 10.3390/pharmacy3040330. Epub 2015 Nov 25.
8
Medication dispensing errors in Palestinian community pharmacy practice: a formal consensus using the Delphi technique.
Int J Clin Pharm. 2016 Oct;38(5):1112-23. doi: 10.1007/s11096-016-0338-x. Epub 2016 Jun 30.
9
Nature and management of duplicate medication alerts.
J Am Med Inform Assoc. 2015 Jul;22(4):831-7. doi: 10.1093/jamia/ocv021. Epub 2015 Apr 9.
10
Evaluation of quality indicators for Dutch community pharmacies using a comprehensive assessment framework.
J Manag Care Spec Pharm. 2015 Feb;21(2):144-52. doi: 10.18553/jmcp.2015.21.2.144.

本文引用的文献

1
Medical errors kill almost 100000 Americans a year.
BMJ. 1999 Dec 11;319(7224):1519. doi: 10.1136/bmj.319.7224.1519.
2
Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group.
Arch Intern Med. 1999 Nov 22;159(21):2553-60. doi: 10.1001/archinte.159.21.2553.
4
The impact of computerized physician order entry on medication error prevention.
J Am Med Inform Assoc. 1999 Jul-Aug;6(4):313-21. doi: 10.1136/jamia.1999.00660313.
5
Clinical pharmacy interventions by community pharmacists during the dispensing process.
Br J Clin Pharmacol. 1999 Jun;47(6):695-700. doi: 10.1046/j.1365-2125.1999.00964.x.
6
Development of pharmaceutical care in The Netherlands: pharmacy's contemporary focus on the patient.
J Am Pharm Assoc (Wash). 1999 May-Jun;39(3):395-401. doi: 10.1016/s1086-5802(16)30442-9.
7
Medication discussion groups in the Netherlands: five years of experience.
Med Educ. 1999 May;33(5):390-3. doi: 10.1046/j.1365-2923.1999.00365.x.
9
The Pharmacists' Implementation of Pharmaceutical Care (PIPC) model.
Pharm Res. 1997 Feb;14(2):135-44. doi: 10.1023/a:1012032223328.
10
An alternative strategy for studying adverse events in medical care.
Lancet. 1997 Feb 1;349(9048):309-13. doi: 10.1016/S0140-6736(96)08268-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验